1. In Memoriam: Philip Neil Sambrook

   • T. V. Nguyen
   • J. A. Eisman
   • M. J. Seibel

   Obituary 10 May 2012 Pages: 1835 - 1836

   

2. In memoriam: Rubem Lederman

   Obituary 15 May 2012 Pages: 1837 - 1837

3. Frailty and sarcopenia: definitions and outcome parameters

   • C. Cooper
   • W. Dere
   • J.-Y. L. Reginster

   Review 31 January 2012 Pages: 1839 - 1848

   

4. SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions

   • J. C. Davis
   • T. Liu-Ambrose
   • C. A. Marra

   Original Article 10 September 2011 Pages: 1849 - 1857

   

5. Mortality after vertebral fracture in Korea

   • Y.-K. Lee
   • S. Jang
   • D.-Y. Kim

   Original Article 23 November 2011 Pages: 1859 - 1865

   

6. A follow-up association study of two genetic variants for bone mineral density variation in Caucasians

   • L.-S. Zhang
   • H.-G. Hu
   • H.-W. Deng

   Original Article 09 December 2011 Pages: 1867 - 1875

   

7. Association of CDX1 binding site of periostin gene with bone mineral density and vertebral fracture risk

   • S.-M. Xiao
   • Y. Gao
   • A. W. C. Kung

   Original Article Open access 04 January 2012 Pages: 1877 - 1887

   

8. Polymorphisms in the human ALOX12 and ALOX15 genes are associated with peak bone mineral density in Chinese nuclear families

   • W.-J. Xiao
   • Y.-H. Ke
   • Z.-L. Zhang

   Original Article 17 November 2011 Pages: 1889 - 1897

   

9. A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma

   • S. Ermakov
   • S. Trofimov
   • G. Livshits

   Original Article 05 November 2011 Pages: 1899 - 1907

   

10. Hydrolyzed collagen improves bone status and prevents bone loss in ovariectomized C3H/HeN mice

    • F. Guillerminet
    • V. Fabien-Soulé
    • A. Blais

    Original Article 17 September 2011 Pages: 1909 - 1919

    

11. Risk factors for osteoporosis in long-term survivors of intracranial germ cell tumors

    • M. J. Kang
    • S. M. Kim
    • J. S. Lim

    Original Article 05 November 2011 Pages: 1921 - 1929

    

12. A clinical decision rule to enhance targeted bone mineral density testing in healthy mid-life women

    • G. Hawker
    • A. Mendel
    • S. Jaglal

    Original Article 10 December 2011 Pages: 1931 - 1938

    

13. Lactation is associated with greater maternal bone size and bone strength later in life

    • P. K. Wiklund
    • L. Xu
    • S. Cheng

    Original Article 17 September 2011 Pages: 1939 - 1945

    

14. Relationship between calcaneal quantitative ultrasound and hip dual energy X-ray absorptiometry in young healthy men

    • J. Rawal
    • K. Eleftheriou
    • H. Montgomery

    Original Article 06 January 2012 Pages: 1947 - 1956

    

15. Vertebral body bone strength: the contribution of individual trabecular element morphology

    • I. H. Parkinson
    • A. Badiei
    • N. L. Fazzalari

    Original Article 16 November 2011 Pages: 1957 - 1965

    

16. Comparative high-resolution pQCT analysis of femoral neck indicates different bone mass distribution in osteoporosis and osteoarthritis

    • A. Rubinacci
    • D. Tresoldi
    • G. Rizzo

    Original Article 24 September 2011 Pages: 1967 - 1975

    

17. Assessment of technical and biological parameters of volumetric quantitative computed tomography of the foot: a phantom study

    • K. E. Smith
    • B. R. Whiting
    • F. W. Prior

    Original Article 07 December 2011 Pages: 1977 - 1985

    

18. Phalangeal quantitative ultrasound in 1,719 children and adolescents with bone disorders

    • A. Mussa
    • F. Porta
    • A. Corrias

    Original Article 23 September 2011 Pages: 1987 - 1998

    

19. Anatomical distribution of vertebral fractures: comparison of pediatric and adult spines

    • K. Siminoski
    • K.-C. Lee
    • STOPP Consortium

    Original Article 23 November 2011 Pages: 1999 - 2008

    

20. Fat mass is negatively associated with bone mineral content in Koreans

    • J. H. Kim
    • H. J. Choi
    • N. H. Cho

    Original Article 18 October 2011 Pages: 2009 - 2016

    

21. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages

    • L. Desjardins
    • S. Liabeuf
    • on behalf of the European Uremic Toxin (EUTox) Work Group

    Original Article 23 November 2011 Pages: 2017 - 2025

    

22. Serum adiponectin and bone mineral density in male hemodialysis patients

    • S. Okuno
    • E. Ishimura
    • M. Inaba

    Original Article 17 September 2011 Pages: 2027 - 2035

    

23. Evaluation of panoramic radiomorphometric indices related to low bone density in sickle cell disease

    • F. S. Neves
    • L. S. A. F. Oliveira
    • I. Crusoé-Rebello

    Original Article 18 October 2011 Pages: 2037 - 2042

    

24. Quality of life and health status with zoledronic acid and generic alendronate—a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass

    • P. Hadji
    • V. Ziller
    • P. H. Kann

    Original Article 16 November 2011 Pages: 2043 - 2051

    

25. Soluble fatty acid synthase relates to bone biomarkers in prepubertal children

    • A. Prats-Puig
    • T. Puig
    • A. López-Bermejo

    Short Communication 30 August 2011 Pages: 2053 - 2058

26. Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis

    • M. Yilmaz
    • H. Taninmis
    • A. Unsal

    Case Report 26 January 2012 Pages: 2059 - 2062

    

27. Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis

    • B. Jönsson
    • O. Ström
    • J. A. Kanis

    Letter 16 November 2011 Pages: 2063 - 2065